Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.

Gerd R Burmester,Vibeke Strand,Alan J Kivitz,Chih-Chi Hu,Sheldon Wang,Hubert van Hoogstraten,Gabriella L Klier,Roy Fleischmann

Rheumatology (Oxford, England)（2023）

引用 0|浏览24

暂无评分

摘要

EXTEND, ClinicalTrials.gov, https://www.clinicaltrials.gov/ct2/show/NCT01146652, NCT01146652; MONARCH OLE, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT02332590, NCT02332590.

查看译文

关键词

DMARDs,biologic therapies,cytokines and inflammatory mediators,rheumatoid arthritis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要